The Xero Ltd (ASX: XRO) stock price has fallen 60% since 2025, as the below chart shows. But a valuation decline does not necessarily make a business a great buy.
As a software business, the company may be at risk of disruption due to AI, according to some investors.
However, I think the best thing Australians can do is judge the company based on its actual financial results. We can't know every detail of the future, but the numbers in the results will show whether the company is actually being affected, or the fear is just fear.
The latest numbers we can judge the business on are from the FY27 half-year result, which showed ongoing growth.

Image source: Getty Images
Strong growth in HY27
For the six months to 30 September 2026, it reported operating revenue growth of 46% to $1.75 billion, customer count grew 12% to 5.15 million, the average revenue per customer increased 25% to $62.21, and annualised monthly recurring revenue (AMRR) soared 41% to $3.84 billion.
However, profitability metrics declined as a result of the Melio acquisition. Acquiring it came at a cost, and it's also loss-making at this stage, affecting the overall profit numbers. Free cash flow declined 26% to $238 million, EBITDA (operating profit) dropped 8% to $348 million, and net profit fell 86% to $18.5 million.
Xero also revealed what the numbers would have been if the company had owned Melio in both reporting periods, as pro forma figures, to indicate the actual progression. Pro forma operating revenue grew 27% to $1.75 billion, pro forma free cash flow increased 32% to $238 million, and pro forma underlying net profit (adjusted NPATA) increased 159% to $81.1 million.
In my view, those numbers still show solid growth for the company, and its underlying profitability is growing at a good pace.
With AMRR continuing to grow at a very strong pace, software economics can help its earnings grow faster than revenue.
Based on Commsec's projections, the business is now trading at approximately 25x FY29's estimated earnings, with earnings per share (EPS) growth of 75% in FY29.
Is the Xero stock price a buy?
I think Xero has been sold off too much given that its underlying earnings continue to grow strongly. It looks like a bargain to me.
Melio is currently unprofitable, but the business is expected to reach breakeven on an adjusted EBITDA basis during 2028. Xero expects Melio to deliver strong revenue growth, expand gross profit margins and accelerate operating leverage.
For FY27, Xero expects to grow its revenue by between 24% and 27%. With its HY27 results, it upgraded its FY27 adjusted EBITDA guidance to between $880 million and $920 million.
I'm not the only one who thinks the Xero share price is undervalued. According to Commsec, there are 13 analyst ratings on the business, with 12 of them a buy call.
If customer growth and loyalty remain strong, then I'd say Xero has a very good future.